The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: -1.00 (-2.38%)
Spread: 2.00 (5.00%)
Open: 42.00
High: 42.00
Low: 41.00
Prev. Close: 42.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of Annual Report and Notice of AGM

20 Nov 2020 07:00

RNS Number : 9439F
Frontier IP Group plc
20 November 2020
 

RNS

AIM: FIPP

20 November 2020

 

 

 

Frontier IP Group plc

("Frontier IP" or the "Company")

 

Posting of Annual Report and Accounts and Notice of Annual General Meeting

 

Frontier IP (AIM: FIPP), a specialist in commercialising intellectual property, announces that its Annual Report and Accounts for the year ended 30 June 2020 were posted to shareholders yesterday. A copy of the Annual Report and Accounts, which includes notice of the Company's Annual General Meeting ("AGM"), is also available to download from the Company's website at www.frontierip.co.uk.

 

The AGM will be held at 93 George Street, Edinburgh, EH2 SE3 at 11 a.m. on 17 December 2020. In light of social distancing measures as a response to the Coronavirus (COVID-19) pandemic, and as permitted by The Corporate Insolvency and Governance Act 2020, this year's AGM will be run as a closed meeting and shareholders will not be permitted to attend the AGM. The Board is taking these steps to adhere to the UK Government guidelines and to protect the Company's shareholders, employees, the Board and the wider community.

 

While the pandemic restricts the Company's ability to allow shareholders the opportunity to attend the AGM in person, the Board will make arrangements so that the legal requirement to hold the meeting can be satisfied through the attendance of two Frontier IP director/shareholders. Any shareholders attempting to attend the AGM will be refused entry on the grounds of public safety.

The outcome of the resolutions to be proposed at the AGM will be determined by the proxy votes received ahead of the AGM. We strongly encourage all shareholders to vote by proxy on all of the resolutions contained in the AGM notice and to appoint the Chairman as proxy in view of the restrictions on attendance. The business at the AGM will be restricted to the formal business only, with no wider presentations on business performance or Q and A.

While shareholders will not be able to attend the AGM in person, the Board's engagement with shareholders and the continued support of shareholders is very important to the Company. Therefore, should shareholders have a question in relation to any of the resolutions to be proposed at the AGM, the Annual Financial Statements or the business of the Company, questions should be submitted to frontier@frontierip.co.uk by noon on 15 December 2020 (including 'AGM 2020' in the subject heading). Questions will be grouped into themes and addressed on the Company's website as soon as practicable following the AGM.

Enquiries

Frontier IP Group plc

0207 332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

07464 546 025

www.frontierip.co.uk

Allenby Capital Limited (Nominated Adviser)

0203 328 5656

Nick Athanas / James Hornigold

N+1 Singer (Broker)

0207 496 3000

Sandy Fraser / Harry Gooden / George Tzimas

 

About Frontier IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANFNFAKEFFA
Date   Source Headline
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.